ArticlePloS one2025
Interpretable ensemble learning model with shapley additive explanations for predicting anxiety symptoms risk in Chinese older adults with body shape index abnormality.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to construct and validate an interpretable risk prediction model for anxiety symptoms in Chinese older adults with abnormal body shape, explore the association between A Body Shape Index (ABSI) and anxiety symptoms, and identify key predictive factors via explainable methods. Data were from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) 2008-2014 (n = 1,844/2,663/3,058 for 2008/2011/2014). The 2008 data (80% training, 20% internal validation) and 2011/2014 data (external validation) were used. Feature selection, data balancing, ensemble learning (Boosting/Stacking/Voting), and Shapley Additive exPlanations (SHAP) were applied. ABSI was positively associated with anxiety symptoms (P = 0.038), with stronger effects in males (trend slope = 0.03) than females (0.02); female anxiety prevalence (39.37%) was higher than males (20.79%). The Boosting-ADASYN model performed best (internal AUC = 0.814, external AUC = 0.766-0.772). SHAP identified marital status, age, self-reported health, education, and happiness as top predictors. ABSI outperformed BMI in capturing abnormal body fat distribution. This study provides an interpretable tool for early anxiety identification in this population, supporting precise interventions combining ABSI and psychosocial strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.